BioCareSD Adds UPLIZNA® to Specialty Therapeutics Portfolio

Leading Specialty Distributor Expands Product Offering to Service Wider Patient Population

TEMPE, Ariz. – October 22, 2021 – BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of UPLIZNA® to its specialty therapeutics portfolio to service a wider patient population and broaden the company’s diverse product offering. Adding UPLIZNA® to its extensive portfolio of life-saving therapies exemplifies BioCareSD’s continued commitment to growing its offering to meet customer demand and provide essential products when patients need them most.  

UPLIZNA® is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive. Effective October 2021, this essential medication will be available through BioCareSD’s dependable specialty distribution network.

With more than 40 years of specialty distribution experience, BioCareSD is dedicated to increasing fast and easy access to life-saving medications across ultra-rare, rare, and orphan diseases. Trusted by manufacturers and healthcare providers nationwide, BioCareSD is a highly agile and nimble organization that offers customizable solutions to ensure best-in-class customer service and high-quality patient care. 

“We are continuously anticipating, identifying and supporting the unmet needs of our customers,” said Andrew Kirk, chief operating officer at BioCareSD. “And we are committed to broadening our portfolio of product offerings as new life-saving medications become available, further increasing access to critical therapeutics that serve more patient groups.”

The addition of UPLIZNA® comes shortly after BioCareSD added TEPEZZA® and KRYSTEXXA® to its product portfolio. Dedicated to ensuring life-sustaining therapies are delivered where and when they are needed, BioCareSD will continue to diversify its offerings to meet customer demand. 

For more information, please visit

About BioCareSD 

BioCareSD is a leading national specialty distributor of life-saving therapies. Headquartered in Tempe, Arizona, BioCareSD has been devoted to delivering specialty and therapeutic biological products since 1982. BioCareSD is part of BioCare, Inc., which encompasses CanyonCareRX, a full-service specialty pharmacy, and LogiCare3PL, a national provider of time and temperature-sensitive pharmaceutical logistics services. BioCare, Inc.’s parent company is Vitalant. Founded in 1943, Vitalant is the nation’s largest independent, nonprofit blood services provider exclusively focused on providing lifesaving blood and comprehensive transfusion medicine services for about 900 hospitals and their patients across the U.S. For more information about BioCareSD, please visit   


Media Contact:  
Gillian Boraiko, Crowe PR | 847.971.7148 

Back to news